Literature DB >> 15905713

Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.

Mimouna Seddik, Hugues Melliez, David Seguy, Nathalie Viget, Antoine Cortot, Jean Frederic Colombel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905713     DOI: 10.1097/01.mib.0000164002.32735.c2

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  6 in total

Review 1.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  [Risk of infection during treatment with tumor necrosis factor-alpha inhibitors].

Authors:  A Gaemperli; T Hauser; R Speck
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

3.  Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFalpha naive patient with ulcerative colitis.

Authors:  James C Lee; Deborah C Bell; Richard M Guinness; Tariq Ahmad
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

4.  Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.487

5.  Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Authors:  Sally J Lawrence; Manish Sadarangani; Kevan Jacobson
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

6.  Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia.

Authors:  Takuya Iwama; Aki Sakatani; Mikihiro Fujiya; Kazuyuki Tanaka; Shugo Fujibayashi; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Kentaro Moriichi; Katsuya Ikuta
Journal:  Gut Pathog       Date:  2016-02-02       Impact factor: 4.181

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.